
欧洲家庭输液治疗市场预测至 2028 年 - COVID-19 影响和按产品(输液泵、静脉注射器、静脉插管和无针连接器)、应用(抗感染、内分泌、肠内营养、水化治疗、化疗、专业)进行区域分析药品等)和给药途径(肌内、皮下和硬膜外)
No. of Pages: 168 | Report Code: BMIRE00028362 | Category: Life Sciences
No. of Pages: 168 | Report Code: BMIRE00028362 | Category: Life Sciences
很多时候,患者需要留在医院完成静脉注射药物的疗程,然后才能转为口服药物。然而,通过有效的家庭输液服务,这些患者可以提前回家。家庭医院模式在家庭环境中提供医院级别的护理,以支持改善结果并增强患者体验。因此,通过家庭输液疗法治疗多种复杂的医疗状况的可能性有助于缩短住院时间,从而降低治疗成本。
家庭输液可显着节省成本与传统的医院输液环境相比。在家中提供的输液费用比在医院设施中提供的输液费用低 50%。根据贝克斯医院2020年发表的文章,家庭输液平均费用为每天140-250美元,而医院输液平均每位患者每次输液费用为590美元。据英联邦基金会称,家庭医院计划有助于将护理成本降低 30% 以上,在英格兰等单一支付系统的国家表现非常好。
急诊室需要静脉注射治疗的患者经临床评估后可转入家庭输液。家庭护理计划包括在家中进行强有力的临床监测,从而可以及早发现进一步的临床问题并实施治疗计划,以避免再次入院。一项针对 124 名家庭肠外营养 (HPN) 和 126 名家庭肠内营养 (HEN) 患者的 Option Care 研究表明,家庭输液可防止住院并改善患者护理。 HPN 和 HEN 疗法都可以暂时在医院进行,但每年约有 40,000 名 HPN 患者和 344,000 名 HEN 患者在家接受营养治疗。因此,护理成本的显着降低、住院时间的缩短以及利用家庭护理服务的患者数量的增加,推动了家庭输液治疗市场的增长。
欧洲家庭输液治疗市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。该地区在家庭输液治疗市场中占有重要的市场份额。由于老年人口的显着增长、癌症和糖尿病发病率的增加以及政府对该地区治疗的有利举措等因素,预计欧洲家庭输液治疗市场在预测期内将出现显着增长。 span>
欧洲家庭输液治疗市场分为产品、应用、给药途径和国家。
根据产品,家庭输液治疗市场分为输液泵、静脉注射器、静脉插管和无针连接器。家庭输液治疗市场细分为胰岛素泵、弹性泵、注射泵等。 2022年,输液泵细分市场占据最大市场份额。
根据应用,家庭输液治疗市场细分为肠内营养、抗感染、内分泌、补液治疗、化疗、特种药物等。 2022年,抗感染药物占据最大市场份额。
根据给药途径,家庭输液治疗市场分为肌内注射、皮下注射和硬膜外注射。 2022 年,肌肉注射细分市场占据最大市场份额。
按国家/地区划分,欧洲家庭输液治疗市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。德国在 2022 年占据市场主导地位。
B. Braun Melsungen AG;麦克雷尔医疗器械公司;百特国际公司;尼普罗公司;贝克顿·迪金森公司;费森尤斯·卡比股份公司; ICU 医疗公司; JMS有限公司;埃坦医疗有限公司; Terumo Corp 是欧洲家庭输液治疗市场的领先公司。
Strategic insights for Europe Home Infusion Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 4,482.33 Million |
Market Size by 2028 | US$ 7,281.99 Million |
Global CAGR (2022 - 2028) | 8.4% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Home Infusion Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Home Infusion Therapy Market is valued at US$ 4,482.33 Million in 2022, it is projected to reach US$ 7,281.99 Million by 2028.
As per our report Europe Home Infusion Therapy Market, the market size is valued at US$ 4,482.33 Million in 2022, projecting it to reach US$ 7,281.99 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.
The Europe Home Infusion Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Home Infusion Therapy Market report:
The Europe Home Infusion Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Home Infusion Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Home Infusion Therapy Market value chain can benefit from the information contained in a comprehensive market report.